| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9945896 | The Annals of Thoracic Surgery | 2005 | 7 Pages |
Abstract
The VCAB was feasible and potentially safe in the short-term postoperative follow-up, particularly with increasing experience after the first patients. Though the VSTENT is a promising tool for myocardial revascularization, long-term safety, patency, and performance of the device needs to be determined.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Calin MD, Bruno MD, Sandra MD, Philip MD, Rabea DVM, Gerhard MD, Peter MD,